13D/13G Filings - Avoro Capital Advisors LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-09-26
5:27 pm
Purchase
2022-09-22 13D Whitehawk Therapeutics Inc
WHWK
Avoro Capital Advisors LLC 3,471,752
14.400%
1,260,000increase
(+56.97%)
Filing
History
2022-02-11
10:09 am
Unchanged
2021-12-31 13G POINT Biopharma Global Inc.
PNT
Avoro Capital Advisors LLC 0
0.000%
0
(Unchanged)
Filing
History
2022-02-11
10:08 am
Sale
2021-12-31 13G Relmada Therapeutics, Inc.
RLMD
Avoro Capital Advisors LLC 0
0.000%
-1,525,000decrease
(Position Closed)
Filing
History
2022-02-11
10:08 am
Sale
2021-12-31 13G Fennec Pharmaceuticals Inc.
FENC
Avoro Capital Advisors LLC 1,200,000
4.600%
-470,000decrease
(-28.14%)
Filing
History
2022-02-11
10:07 am
Sale
2021-12-31 13G Avadel Pharmaceuticals plc
AVDL
Avoro Capital Advisors LLC 1,670,000
2.900%
-2,695,000decrease
(-61.74%)
Filing
History
2022-02-11
10:07 am
Sale
2021-12-31 13G Arena Pharmaceuticals, Inc.
ARNA
Avoro Capital Advisors LLC 1,235,000
2.000%
-2,955,000decrease
(-70.53%)
Filing
History
2022-02-11
10:06 am
Sale
2021-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
Avoro Capital Advisors LLC 1,465,000
3.200%
-885,267decrease
(-37.67%)
Filing
History
2022-02-11
10:06 am
Purchase
2021-12-31 13G Monte Rosa Therapeutics, Inc.
GLUE
Avoro Capital Advisors LLC 3,311,434
7.100%
3,311,434increase
(New Position)
Filing
History
2022-02-11
10:05 am
Purchase
2021-12-31 13G Amicus Therapeutics, Inc.
FOLD
Avoro Capital Advisors LLC 18,500,000
6.600%
7,300,000increase
(+65.18%)
Filing
History
2022-02-11
10:05 am
Purchase
2021-12-31 13G IO Biotech, Inc.
IOBT
Avoro Capital Advisors LLC 2,055,883
7.100%
2,055,883increase
(New Position)
Filing
History
2022-02-11
10:04 am
Purchase
2021-12-31 13G Apellis Pharmaceuticals, Inc.
APLS
Avoro Capital Advisors LLC 8,555,555
8.900%
8,555,555increase
(New Position)
Filing
History
2022-02-11
10:04 am
Purchase
2021-12-31 13G Iovance Biotherapeutics, Inc.
IOVA
Avoro Capital Advisors LLC 8,675,000
5.500%
1,175,000increase
(+15.67%)
Filing
History
2022-02-11
10:03 am
Purchase
2021-12-31 13G Madrigal Pharmaceuticals, Inc.
MDGL
Avoro Capital Advisors LLC 1,425,000
8.300%
200,000increase
(+16.33%)
Filing
History
2022-02-11
10:03 am
Purchase
2021-12-31 13G CymaBay Therapeutics, Inc.
CBAY
Avoro Capital Advisors LLC 12,800,000
14.700%
2,500,000increase
(+24.27%)
Filing
History
2022-02-11
10:02 am
Purchase
2021-12-31 13G United Therapeutics Corporation
UTHR
Avoro Capital Advisors LLC 3,035,000
6.700%
185,000increase
(+6.49%)
Filing
History
2022-02-11
10:01 am
Sale
2021-12-31 13G Adverum Biotechnologies, Inc.
ADVM
Avoro Capital Advisors LLC 695,000
7.100%
-105,000decrease
(-13.12%)
Filing
History
2022-02-11
10:01 am
Purchase
2021-12-31 13G Marinus Pharmaceuticals, Inc.
MRNS
Avoro Capital Advisors LLC 3,235,000
8.800%
2,858increase
(+0.09%)
Filing
History
2022-02-11
10:01 am
Purchase
2021-12-31 13G Mirati Therapeutics, Inc.
MRTX
Avoro Capital Advisors LLC 5,075,000
9.200%
540,000increase
(+11.91%)
Filing
History
2022-02-11
10:00 am
Purchase
2021-12-31 13G Xenon Pharmaceuticals Inc.
XENE
Avoro Capital Advisors LLC 4,985,000
9.700%
2,185,000increase
(+78.04%)
Filing
History
2021-11-24
3:48 pm
Sale
2021-11-22 13D Acceleron Pharma Inc.
XLRN
Avoro Capital Advisors LLC 0
0.000%
-4,476,100decrease
(Position Closed)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next